ArticleSmall science2025
Investigating Extracellular Vesicles in Viscous Formulations: Interplay of Nanoparticle Tracking and Nanorheology via Interferometric Light Microscopy.
Article in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Post-encapsulation methods for the preparation of mRNA-LNPs.Drug delivery and translational research · 2025Article
- Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis.ACS nano · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While extracellular vesicles (EVs) demonstrate growing potential as innovative cell-derived nanobiotherapies in diverse medical contexts, their physical properties (size, integrity, transport, etc.) in drug product formulation remain a critical concern poorly addressed so far. Herein, a methodology that relies on nanoparticle tracking analysis by interferometric light microscopy (ILM) for analyzing the concentration and size distribution of nanoparticles as well as their interactions with their local environment through a nanorheological approach is introduced. The analysis of interference patterns enables nanoparticles tracking not only in aqueous solutions but also in complex media with high-viscosity or non-Newtonian behavior, particularly pertinent for characterizing EV formulations. A proof of concept for in situ tracking of EVs suspended in Poloxamer-407 as drug delivery system is presented. The ILM-based analysis enables to 1) measure the viscosity at the nanoscale for Newtonian and non-Newtonian fluids via calibration beads; 2) analyze data to determine the size distribution of EVs in non-Newtonian complex fluid such as poloxamer formulation, and 3) analyze the interactions of EVs with poloxamer-407. The proposed approach represents a valuable tool to understand the nanorheological behavior of EVs in viscoelastic media in situ as well as a quality control test for EV formulations intended to clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.